Fostemsavir Decreases the Levels of Anti-gp120 CD4-Induced Antibodies in Heavily Treatment-Experienced People With HIV

Authors

Institutions

Publication Details

Journal
The Journal of Infectious Diseases
Published
2025-09-20
DOI
https://doi.org/10.1093/infdis/jiaf461
Primary Topic
HIV Research and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Fostemsavir Decreases the Levels of Anti-gp120 CD4-Induced Antibodies in Heavily Treatment-Experienced People With HIV

Madéleine Durand, Tommaso Clemente, Jonathan Richard, Mehdi Benlarbi et al.
The Journal of Infectious Diseases
HIV Research and Treatment
article

Fostemsavir Decreases the Levels of Anti-gp120 CD4-Induced Antibodies in Heavily Treatment-Experienced People With HIV

Madéleine Durand, Tommaso Clemente, Jonathan Richard, Mehdi Benlarbi, Marzena Pazgier, William D. Tolbert, Catherine Bourassa, Antonella Castagna, Manyu Prakash, Andrew L. Clark, Andrés Finzi, Monika Chandravanshi
article en

Abstract

No abstract available for this paper.
The Journal of Infectious DiseasesVol. 233(2)
Uniformed Services University of the Health Sciences (US), Vita-Salute San Raffaele University (IT), ViiV Healthcare (United Kingdom) (GB), Centre Hospitalier de l’Université de Montréal (CA), Istituti di Ricovero e Cura a Carattere Scientifico (IT), Université de Montréal (CA)
Openalex Percentile: Top 72%
HIV Research and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.